77.4 F
New York
Thursday, July 29, 2021

AstraZeneca [NYSE: AZN] And Sanofi’s [NASDAQ: SNY] Nirsevimab Shows Positive Result In Phase 2 Trial

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

AstraZeneca PLC [NYSE: AZN] and development partner Sanofi’s [NASDAQ: SNY] nirsevimab has shown a promising result in Phase 2 clinical trial, companies disclosed today. Both Sanofi and AstraZeneca have signed an agreement in March 2017 for the development and commercialization of Nirsevimab.

The current Phase 2 study result has shown a significant reduction in Respiratory Syncytial Virus (RSV) infections which required medical care in the healthy premature infant. Nirsevimab has decreased the infections by 70% and the need for medical care by 78%.

Respiratory Syncytial Virus (RSV) is a lower respiratory tract infection. RSV is a contagious virus that infects the respiratory tract and the most common cause of pneumonia and bronchiolitis. Nirsevimab which is co-developed by Sanofi and AstraZeneca reduced the infections caused by RSV in infants who are experiencing their first RSV season.

Shares of AstraZeneca traded up 0.57% during the trading of Wednesday. Its closing price is $56.64. AZN has a 52-weeks low and high range of $36.15-$64.94, respectively. AZN has a day high range of $57.05 and a day low range of $56.09.

It had a trading volume of roughly 5.04 million as compared to the average volume of 7.14 million. Continuing to look at its profitability, its return on assets (ROA) is 2.50%, return on equity (ROE) is 12.30%, and return on investment (ROI) is 8.30%.

AZN has a Gross Margin of 79.60%, a Profit Margin of 6.00%, and an Operating Margin of 12.10%. Turning our focus on liquidity, its quick ratio is 0.60 and the current ratio is 0.80.

On the other hand, Sanofi’s shares have exhibited a change of 1.95% at $52.84 during the trading session on Wednesday. Its return on investment (ROI) is 3.50%. SNY has a Gross Margin of 68.00%, a Profit Margin of 13.60%, and an Operating Margin of 16.20%.

In the past 52-weeks of trading, its stocks fluctuated between the low of $37.62 and a high of $55.00. SNY has moved up 40.46% from 52-weeks of low range and moved down -3.93% from the 52-weeks of high range.

Phase 2b trial of Nirsevimab fulfilled the primary and secondary endpoints. Nirsevimab gained a statistically significant 70.1% (95% CI: 52.3%-81.2%) reduction of medically attended RSV LRTI contrasted to placebo through 150 days post-dose on the primary endpoint.

On the secondary endpoint, nirsevimab achieved a 78.4% (95% CI: 51.9%-90.3%) relative reduction in the need for medical care due to RSV LRTI compared to placebo through 150 days post-dose.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...